Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host.

Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL.

J Virol. 2007 Oct;81(20):11341-51. Epub 2007 Aug 8.

2.
3.

Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine.

Bai X, Bao H, Li P, Sun P, Kuang W, Cao Y, Lu Z, Liu Z, Liu X.

Virol J. 2010 Aug 31;7:208. doi: 10.1186/1743-422X-7-208.

4.

Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host.

Núñez JI, Molina N, Baranowski E, Domingo E, Clark S, Burman A, Berryman S, Jackson T, Sobrino F.

J Virol. 2007 Aug;81(16):8497-506. Epub 2007 May 23.

5.

Examination of soluble integrin resistant mutants of foot-and-mouth disease virus.

Lawrence P, LaRocco M, Baxt B, Rieder E.

Virol J. 2013 Jan 2;10:2. doi: 10.1186/1743-422X-10-2.

6.

Pathogenic characteristics of the Korean 2002 isolate of foot-and-mouth disease virus serotype O in pigs and cattle.

Oem JK, Yeh MT, McKenna TS, Hayes JR, Rieder E, Giuffre AC, Robida JM, Lee KN, Cho IS, Fang X, Joo YS, Park JH.

J Comp Pathol. 2008 May;138(4):204-14. doi: 10.1016/j.jcpa.2008.01.007. Epub 2008 Apr 1.

PMID:
18384806
7.

[Diversity of receptor recognition site of type Asial foot-and-mouth disease virus].

Li P, Bai X, Sun P, Lu Z, Cao W, Wu R, Yin H, Liu Z.

Wei Sheng Wu Xue Bao. 2011 Mar;51(3):423-8. Chinese.

PMID:
21604558
9.

Role of arginine-56 within the structural protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus virulence.

Borca MV, Pacheco JM, Holinka LG, Carrillo C, Hartwig E, Garriga D, Kramer E, Rodriguez L, Piccone ME.

Virology. 2012 Jan 5;422(1):37-45. doi: 10.1016/j.virol.2011.09.031. Epub 2011 Oct 27.

10.

Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Rodríguez Pulido M, Sobrino F, Borrego B, Sáiz M.

J Virol. 2009 Apr;83(8):3475-85. doi: 10.1128/JVI.01836-08. Epub 2009 Feb 11.

11.

Capsid coding sequences of foot-and-mouth disease viruses are determinants of pathogenicity in pigs.

Lohse L, Jackson T, Bøtner A, Belsham GJ.

Vet Res. 2012 May 24;43:46. doi: 10.1186/1297-9716-43-46.

12.

High throughput sequencing and comparative genomics of foot-and-mouth disease virus.

Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL.

Dev Biol (Basel). 2006;126:23-30; discussion 323.

PMID:
17058478
13.

Differential Persistence of Foot-and-Mouth Disease Virus in African Buffalo Is Related to Virus Virulence.

Maree F, de Klerk-Lorist LM, Gubbins S, Zhang F, Seago J, Pérez-Martín E, Reid L, Scott K, van Schalkwyk L, Bengis R, Charleston B, Juleff N.

J Virol. 2016 Apr 29;90(10):5132-40. doi: 10.1128/JVI.00166-16. Print 2016 May 15.

14.

Evaluation of Infectivity, Virulence and Transmission of FDMV Field Strains of Serotypes O and A Isolated In 2010 from Outbreaks in the Republic of Korea.

Pacheco JM, Lee KN, Eschbaumer M, Bishop EA, Hartwig EJ, Pauszek SJ, Smoliga GR, Kim SM, Park JH, Ko YJ, Lee HS, Tark D, Cho IS, Kim B, Rodriguez LL, Arzt J.

PLoS One. 2016 Jan 6;11(1):e0146445. doi: 10.1371/journal.pone.0146445. eCollection 2016.

15.

Genetic variation of foot-and-mouth disease virus isolates recovered from persistently infected water buffalo (Bubalus bubalis).

Barros JJ, Malirat V, Rebello MA, Costa EV, Bergmann IE.

Vet Microbiol. 2007 Feb 25;120(1-2):50-62. Epub 2006 Oct 25.

PMID:
17113729
16.

Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population.

Sanz-Ramos M, Rodríguez-Calvo T, Sevilla N.

PLoS One. 2012;7(6):e39941. doi: 10.1371/journal.pone.0039941. Epub 2012 Jun 28.

17.

Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus.

Pacheco JM, Henry TM, O'Donnell VK, Gregory JB, Mason PW.

J Virol. 2003 Dec;77(24):13017-27.

18.

Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region.

Lv K, Guo Y, Zhang Y, Wang K, Li K, Zhu Y, Sun S.

Res Vet Sci. 2009 Jun;86(3):443-52. doi: 10.1016/j.rvsc.2008.10.011. Epub 2008 Dec 4.

PMID:
19062053
19.
20.

Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.

Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.

Vaccine. 2008 Mar 10;26(11):1471-81. doi: 10.1016/j.vaccine.2007.12.053. Epub 2008 Jan 24.

PMID:
18289743

Supplemental Content

Support Center